Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy

Autor: Ayako Nagayama, Kenji Ashida, Miki Watanabe, Kanoko Moritaka, Aya Sonezaki, Yoichiro Kitajima, Hirokazu Takahashi, Satoko Yoshinobu, Shimpei Iwata, Junichi Yasuda, Nao Hasuzawa, Shuichi Ozono, Seiichi Motomura, Masatoshi Nomura

Publikováno v: Frontiers in Endocrinology, Vol 12 (2021)

Childhood cancer survivors (CCSs) who have undergone bone marrow transplantation with systemic chemotherapy and whole-body irradiation often experience impaired glucose tolerance with marked insulin resistance. Incomplete acquired diabetic lipodystro

Externí odkaz: https://doaj.org/article/8bc54ae3c6754fe7b443a7942babbf89

Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients

Autor: Christoph B. Geier, Maryssa Ellison, Rachel Cruz, Sumit Pawar, Alexander Leiss-Piller, Katarina Zmajkovicova, Shannon M McNulty, Melis Yilmaz, Martin Oman Evans, Sumai Gordon, Boglarka Ujhazi, Ivana Wiest, Hassan Abolhassani, Asghar Aghamohammadi, Sara Barmettler, Saleh Bhar, Anastasia Bondarenko, Audrey Anna Bolyard, David Buchbinder, Michaela Cada, Mirta Cavieres, James A. Connelly, David C. Dale, Ekaterina Deordieva, Morna J. Dorsey, Simon B. Drysdale, Stephan Ehl, Reem Elfeky, Francesca Fioredda, Frank Firkin, Elizabeth Förster-Waldl, Bob Geng, Vera Goda, Luis Gonzalez-Granado, Eyal Grunebaum, Elzbieta Grzesk, Sarah E. Henrickson, Anna Hilfanova, Mitsuteru Hiwatari, Chihaya Imai, Winnie Ip, Soma Jyonouchi, Hirokazu Kanegane, Yuta Kawahara, Amer M. Khojah, Vy Hong-Diep Kim, Marina Kojić, Sylwia Kołtan, Gergely Krivan, Daman Langguth, Yu-Lung Lau, Daniel Leung, Maurizio Miano, Irina Mersyanova, Talal Mousallem, Mica Muskat, Flavio A. Naoum, Suzie A. Noronha, Monia Ouederni, Shuichi Ozono, G. Wendell Richmond, Inga Sakovich, Ulrich Salzer, Catharina Schuetz, Filiz Odabasi Seeborg, Svetlana O. Sharapova, Katja Sockel, Alla Volokha, Malte von Bonin, Klaus Warnatz, Oliver Wegehaupt, Geoffrey A. Weinberg, Ke-Juin Wong, Austen Worth, Huang Yu, Yulia Zharankova, Xiaodong Zhao, Lisa Devlin, Adriana Badarau, Krisztian Csomos, Marton Keszei, Joao Pereira, Arthur G Taveras, Sarah L. Beaussant-Cohen, Mei-Sing Ong, Anna Shcherbina, Jolan E. Walter

Publikováno v: Journal of Clinical Immunology. 42:1748-1765

Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome (WS) is a combined immunodeficiency caused by gain-of-function mutations in the C-X-C chemokine receptor type 4 (CXCR4) gene. We characterize a unique international cohort of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec3dbe757488d15524fabc139819f46
https://doi.org/10.1007/s10875-022-01312-7

Systemic inflammation caused by an intracranial mesenchymal tumor with a EWSR1 :: CREM fusion presenting associated with IL ‐6/ STAT3 signaling

Autor: Keishiro Hojo, Takuya Furuta, Satoru Komaki, Yukako Yoshikane, Jin Kikuchi, Hideo Nakamura, Mizuki Ide, Saho Shima, Yusuke Hiyoshi, Junichiro Araki, Seiji Tanaka, Shuichi Ozono, Akihiko Yoshida, Sumihito Nobusawa, Motohiro Morioka, Ryuta Nishikomori

Publikováno v: Neuropathology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::866690e8a66481356c4055bb92cd2ef0
https://doi.org/10.1111/neup.12877

A nationwide survey of late effects in survivors of juvenile myelomonocytic leukemia in Japan

Autor: Shuichi Ozono, Kazuo Sakashita, Nao Yoshida, Harumi Kakuda, Kenichiro Watanabe, Miho Maeda, Yasushi Ishida, Atsushi Manabe, Takashi Taga, Hideki Muramatsu

We conducted a cross-sectional study using a questionnaire to explore the late effects in survivors of allogenic hematopoietic stem cell transplantation (HSCT) for juvenile myelomonocytic leukemia (JMML). The attending pediatric hematologists/oncolog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6284bfcb0054278df58a579a56b18a1c
https://doi.org/10.22541/au.166114802.20666502/v1

A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia

Autor: Nao Yoshida, Atsushi Manabe, Harumi Kakuda, Yuka Nanjo, Toru Meguro, Hideki Sano, Yuko Honda, Hiroshi Moritake, Kazuo Sakashita, Manabu Wakamatsu, Masahiro Yasui, Hideki Muramatsu, Shinsuke Hirabayashi, Shuichi Ozono

Publikováno v: International journal of hematology. 115(2)

Juvenile myelomonocytic leukemia (JMML) is a pediatric hematological malignancy with a poor prognosis. Although several case series have been published describing hematological and molecular responses to azacitidine (AZA) treatment in patients with J

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dc729cd87ad63e86eab98c52183fc2c
https://pubmed.ncbi.nlm.nih.gov/34714526